A number of local movers and shakers with ties to Johns Hopkins have landed on the “40 Under 40” list published by the Baltimore Business Journal.
The journal’s annual list takes note of “innovators, professionals, and entrepreneurs in Greater Baltimore who have already made great strides before the age of 40,” including developers, CEOs, educators, and nonprofit founders. A Nov. 16 ceremony will celebrate this year’s b
The Inova Personalized Health Accelerator (IPHA) announced today that health and biosciences industry veteran Michael Thomas has been appointed Director of the Accelerator. Prior to joining Inova, Michael was founder and CEO of Appian Partners, an Annapolis life sciences consulting practice. His med-tech experience has spanned several early stage, growth stage, and turn-around ventures as CEO of Appian Partners, ReGear Life Sciences, NuSomnea, Tanzen Medical, Mommy’s Medicine Cabinet, Appian Medical, iSonea, and NovaSom. He also served on the board of directors for AdvaMed and Circadiance. He started his career in the pharmaceutical industry with Merck & Company and GlaxoSmithKline. Michael earned a BS in Microbiology from Cornell University.
Dimension Therapeutics has agreed to be acquired by RegenxBio, the gene therapy developer that originally helped form the company four years ago.
RegenxBio (NASDAQ: RGNX), based in Rockville, MD, will pay $3.41 per share in the all-stock deal valued at approximately $86 million. By comparison, Cambridge, MA-based Dimension (NASDAQ: DMTX) went public at $13 per share in 2015. Dimension’s closing stock price on Thursday was $1.20.
The academic biomedical research community is a hub of employment, economic productivity, and scientific progress. Academic research institutions are drivers of economic development in their local and state economies and, by extension, the national economy. Beyond the economic input that the academic biomedical research community both receives and provides, it generates knowledge that in turn affects society in myriad ways.
The 2018 FLC Awards is now open for nominations. One of the most coveted honors in the technology transfer field, the FLC awards have been presented to over 200 federal laboratories since their inception in 1984. Many of our winning technology transfer efforts have gone on to become products and devices that are indispensable in our daily lives, including:
Inova Genomics Laboratory is thrilled to offer you our exclusive MediMap® PGx (pharmacogenomics) panel – as well as tests for up to two family members, if applicable at your event.
What is MediMap?
MediMap is a one-time genetic test that may indicate how a person will respond to some prescription medications. The test helps guide healthcare providers to better medication choices and doses for their patients. MediMap testing provides information to more effectively manage illnesses and improve patients’ health. To learn more, please visit www.inova.org/MediMap. What’s involved?
All that’s needed is a painless cheek swab, which we will conduct after you have registered by filling out the form below.
The PMatX Yavne incubator will serve Israeli startups and focus on next-generation electronics and advanced materials.
German pharmaceutical, life sciences and chemicals giant Merck Group today announced the founding of a technological innovation laboratory that will function as an incubator for startups in Israel. The incubator, to be called PMatX, will focus on next-generation electronics. The program will be supported by other partners, including printing solutions manufacturer HP and the Battery Ventures fund.
New York City’s existing 1.7 million s/f of life science and research space is currently fully occupied, pushing companies to establish outposts in Westchester County and New Jersey.
According to a report from brokerage firm Transwestern, New York City is facing space constraints as it hosts the highest concentration of academic institutions and the largest life science workforce in the country.
It’s a common trope that government has a lot to learn from Silicon Valley when it comes to technology. But in cybersecurity, Washington is leading the way in many respects.
When federal leaders and lawmakers praise industry’s tech savvy, they’re usually talking about innovation, flexibility and speed to market. IT companies aren’t burdened by a labyrinthine acquisition process. They can shift quickly when customers want something different, abandon failing efforts and push products out at the lowest cost.
DATE AND TIME: Tue, September 19, 20177:30 AM – 10:00 AM EDT
LOCATION: American Visionary Art Museum800 Key Highway JRVC 3rd Floor Baltimore, MD 21230
Already dubbed a ‘tech hub’, the Baltimore-Washington region has built a solid foundation in cyber activities as they pertain to government agencies and defense contracting. Now a transformation is underway to build up the commercial side of cyber. And that’s precisely what this panel will reinforce.
